The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 354:934-941 March 2, 2006 Number 9
NextNext

Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation
Hakan Oral, M.D., Carlo Pappone, M.D., Aman Chugh, M.D., Eric Good, D.O., Frank Bogun, M.D., Frank Pelosi, Jr., M.D., Eric R. Bates, M.D., Michael H. Lehmann, M.D., Gabriele Vicedomini, M.D., Giuseppe Augello, M.D., Eustachio Agricola, M.D., Simone Sala, M.D., Vincenzo Santinelli, M.D., and Fred Morady, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Supplementary Material

Commentary
-Editorial
 by Wood, M. A.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
ABSTRACT

Background We conducted a randomized, controlled trial of circumferential pulmonary-vein ablation for the treatment of chronic atrial fibrillation.

Methods A total of 146 patients with a mean (±SD) age of 57±9 years who had chronic atrial fibrillation were randomly assigned to receive amiodarone and undergo two cardioversions during the first three months alone (the control group) or in combination with circumferential pulmonary-vein ablation. Cardiac rhythm was assessed with daily telephonic transmissions for one year. The left atrial diameter and the severity of symptoms were assessed at 12 months.

Results Among the 77 patients assigned to undergo circumferential pulmonary-vein ablation, ablation was repeated because of recurrent atrial fibrillation in 26 percent of patients and atypical atrial flutter in 6 percent. An intention-to-treat analysis showed that 74 percent of patients in the ablation group and 58 percent of those in the control group were free of recurrent atrial fibrillation or flutter without antiarrhythmic-drug therapy at one year (P=0.05). Among the 69 patients in the control group, 53 (77 percent) crossed over to undergo circumferential pulmonary-vein ablation for recurrent atrial fibrillation by one year and only 3 (4 percent) were in sinus rhythm without antiarrhythmic-drug therapy or ablation. There were significant decreases in the left atrial diameter (12±11 percent, P<0.001) and the symptom severity score (59±21 percent, P<0.001) among patients who remained in sinus rhythm after circumferential pulmonary-vein ablation. Except for atypical atrial flutter, there were no complications attributable to circumferential pulmonary-vein ablation.

Conclusions Sinus rhythm can be maintained long term in the majority of patients with chronic atrial fibrillation by means of circumferential pulmonary-vein ablation independently of the effects of antiarrhythmic-drug therapy, cardioversion, or both. The maintenance of sinus rhythm is associated with a significant decrease in both the severity of symptoms and the left atrial diameter.


Source Information

From the Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (H.O., A.C., E.G., F.B., F.P., E.R.B., M.H.L., F.M.); and the Electrophysiology and Cardiac Pacing Department, San Raffaele University Hospital, Milan (C.P., G.V., G.A., E.A., S.S., V.S.).

Drs. Oral and Pappone and Drs. Santinelli and Morady contributed equally to the article as first authors and senior authors, respectively.

Address reprint requests to Dr. Oral at the Division of Cardiovascular Medicine, TCB1 140 D, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-0311, or at oralh{at}umich.edu.

Full Text of this Article


Related Letters:

Circumferential Pulmonary-Vein Ablation for Atrial Fibrillation
Wazni O. M., Fahmy T. S., Natale A., Aberegg S. K., Majure D., Auer J., Lamm G., Eber B., Oral H., Pappone C., Morady F., Wood M. A., Ellenbogen K. A.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:2289-2291, May 25, 2006. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.